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Purpose: To formulate theophylline microspheres with cellulose acetate using solvent evaporation 
method and evaluate the effect of various processing factors on their characteristics.  
Methods: Microspheres containing theophylline were prepared with a hydrophilic, biocompatible 
polymer - cellulose acetate - by an emulsion solvent evaporation technique using an acetone/liquid 
paraffin system containing Span 80 as a surfactant. The effect of processing factors, e.g., varying 
drug/polymer ratio (1:1, 1:2, 1:3) and temperature (10 and 35 °C) on microsphere characteristics and 
drug release were examined. Similarly, microspheres with a drug/polymer ratio of 1:3 incorporating 
Span 20  were also also prepared and evaluated. 
Results: The microspheres were white, free-flowing and spherical. The yield varied from 73.0 to 87.5 % 
while entrapment efficiency was in the region of 71.8 to 92.4 %. High drug/polymer ratio, Span 80 
(surfactant) and processing temperature between 10 and 30 °C produced formulations with better drug 
entrapment efficiency. High drug/polymer ratio, low processing temperature and low HLB value of 
surfactant enhanced the sustained drug release characteristics of the microspheres. 
Conclusion: The combination of three suitable factors - Span mixture (with HLB value of 4.3), 
processing temperature of 10 °C and drug/polymer ratio of 1:3 - produced a suitable controlled release 
theophilline microsphere formulation which could be effective for the management of asthma. 
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INTRODUCTION 
 
The microencapsulation technique by solvent 
evaporation process has been extensively 
studied in recent years for the preparation of 
microspheres. This is a complex process and 
requires strict control of several processing 
parameters such as rate of solvent 
evaporation, stirring rate, viscosity of 
polymeric phase, drug polymer ratio, volume 
ratio between inner phase and outer phase 
and amount of surfactant, in order to develop 
a therapeutically effective dosage form [1].  
 
Some studies have been carried out earlier 
using polymethacrylate polymers (Eudragit 
RS 100, RSPO, etc) and dextran regarding 
the effect of processing temperature on 
microsphere characteristics [1,2] but no work 
has been reported, to the best of our 
knowledge, on the effect of processing 
temperature and Span HLB value on 
cellulose acetate microsphere formulation 
and release characteristics. The role of 
temperature in emulsion solvent evaporation 
process is a matter of great significance since 
it affects the rate and way at which the 
organic solvent is removed from the 
microspheres and ultimately, the shape, size, 




Surface active agents play a significant role 
in microsphere formulation by emulsification 
solvent evaporation method. They have the 
properties of adsorbing to the interface and 
stabilizing the emulsion droplets by 
preventing their aggregation. Cellulose 
acetate (CA) the acetate ester of cellulose is 
a biocompatible hydrophilic polymer and has 
been used as a microencapsulating agent in 
several studies [2- 4]. Theophylline (TH), the 
drug of choice for the treatment of asthma 
has a short elimination half-life, and its 
toxicity is dose-dependent. All the side effects 
can be controlled efficiently if the drug is 
administered as a controlled release 
formulation [5].  
 
To the best of our knowledge, the effect of 
process parameters such as temperature and 
hydrophilic/lipophilic balance (HLB) value of 
surfactant on characteristics of theophylline 
(TH) microspheres prepared with cellulose 
acetate (CA) has not been carried out. 
Therefore, the objective of this study was to 
evaluate the effect of drug/polymer ratio, 
process temperature and surfactant HLB 
value on the shape, size, flow property, drug-
loading efficiency and drug release 
characteristics of theophylline CA 
microspheres prepared by solvent 
evaporation method using acetone/liquid 
paraffin system, as well as determine the 
potentially most suitable controlled release 






Theophylline (TH) and cellulose acetate (CA) 
were obtained as gifts from Macleod, 
Mumbai, India, while Span 20 and 80 were 
procured from Central Drug House (P) Ltd, 
New Delhi, India. All other reagents and 
solvents used were of pharmaceutical or 
analytical grade. 
 
Method of preparation  
 
Cellulose acetate (CA), ranging from 0.25 to 
0.75 g, was dissolved in 10 ml of acetone and 
0.25 g of theophylline (the fraction passing 
through a sieve with aperture size of 36 µm) 
was suspended in the CA solution and stirred 
with a magnetic stirrer. The resultant 
dispersion was poured into 100 ml of light 
liquid paraffin, containing 1.5 %w/v of Span 
80 (HLB value 4.3) as an emulsifying agent, 
in a 250 ml beaker which was rotated in a 
water bath at 600 rpm at 30 °C  for 7 h. The 
resulting microspheres were filtered through 
a Whatman filter paper no. 1. The residue 
was washed 4 - 5 times in 50 ml n-hexane on 
each occasion. The microspheres were dried 
at room temperature for 24 h [6,7]. 
Microspheres with varying drug/polymer ratio 
(1:1, 1:2, 1:3) were coded F1, F2 and F3, 
respectively. Microspheres were also 
prepared with a drug/polymer ratio of 1:3 
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using Span 80 (HLB value, 4.3) at 10 and 35 
°C and denoted F4 and F5, respectively. 
Similarly, microspheres with a drug/polymer 
ratio of 1:3 using Span 20 (HLB value, 8.6) at 
a temperature of 30 °C was denoted F6. 
 
Determination of microsphere yield 
 
The microspheres were weighed and the 
yield of microspheres was calculated using 
Eq 1. 
 
Yield (%) = (A/B) x 100  ………………….. (1) 
where A is the weight of microspheres 
obtained and B is the  theoretically expected 
weight of microspheres.  
 
Assessment of size distribution of 
microspheres  
 
The microspheres were separated into 
different size fractions by sieving for 10 min 
using a mechanical sieve shaker (Cuprit 
Electrical Co., India) containing standard 
sieves with apertures of 710, 500, 355, 250 
and 180 µm, respectively. The particle size 
distribution of each of the microsphere batch 
was determined [7] and their mean particle 
size calculated using Eq 2. 
Mean particle size =Σ (P x W)/Σ W ……… (2)  
where P is the mean particle size of the 




The flow properties of the microspheres were 
evaluated by determining Carr’s index [7] as 
in Eq 3.  
Carr’s index = {(TD – BD) x 100}/TD …… (3) 
 where TD is tapped density and BD bulk 
density. The bulk and tapped densities were 
measured in a 10 ml graduated measuring 
cylinder.  
 
Surface accumulation studies 
 
This study was conducted to estimate the 
amount of drug present on the surface of the 
microspheres. An accurately weighed 
quantity of the microspheres (50 mg) was 
suspended in 50 ml of phosphate buffer (pH 
6.8) and agitated on a mechanical shaker for 
15 min. The amount of drug leached from the 
surface of the microspheres was analyzed 
spectrophotometrically using Systronic 2101 
UV–Visible spectrophotometer at 271 nm and 
expressed as a proportion of the entrapped 
drug in the microspheres [9]. 
 
Drug entrapment efficiency 
 
About 50 mg of accurately weighed 
microspheres were added to 50 ml of 
phosphate buffer, (pH 6.8) and then agitated 
on a mechanical shaker for 24 h. The mixture 
was filtered with Whatman membrane filter, 
BA85 grade (0.45 µm pore size) and, after 
suitable dilution, analyzed 
spectrophotometrically at 271 nm  using 
Systronic 2101 UV – Visible 
spectrophotometer.   
 
Scanning electron microscopy (SEM) 
 
A scanning electron microscope (JEOL JSM 
– 5200) was used to characterize the surface 
topography of the microspheres at 20 kV. 
Prior to examination the microspheres were 
fixed on a metallic support with a thin 
adhesive tape and microspheres were coated 
with gold under vacuum (fine coat, ion sputter 
JFC – 1110) to render them electron 
conductive. 
 
In vitro release studies 
 
In vitro release studies on the microspheres 
(355 µm fraction) were carried out at 37 °C in 
500 ml 0.1M HCl (pH 1.2) for the first 2 h and 
then in 500 ml phosphate buffer (pH 6.8) in a 
USP basket type dissolution test apparatus 
(Labindia, Disso-2000, Mumbai, India) 
rotated at 100 rpm. At preset time intervals, 2 
ml aliquots were withdrawn and replaced by 
an equal volume of fresh dissolution medium. 
The withdrawn samples were filtered (0.45 
µm pore size) and, after suitable dilution, 
analyzed spectophotometrically at 271 nm. 
Each test was carried out in triplicate. 
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Yield (%)  Carr’s 
index 
Mean particle size 





*F1 85.3±4.7  8.81 463±2.6 3.6±0.0.2 78.6±1.3 
*F2 85.4±2.6  7.38 521±4.4 2.1±0.3 86.2±2.0 
*F3 78.5±1.5  4.94 608±2.0 1.2±0.1 90.9±1.8 
**F4 85.2±2.2  5.22 386±3.6 1.4±0.2 93.4±0.9 
***F5 87.5±1.0  9.90 731±2.0 4.0±0.3 71.8±1.2 
¤
F6 72.9±2.6  5.38 747±0.6 12.0±0.5 79.1±2.4 
*Formulations containing drug/polymer ratio of 1:1, 1:2, 1:3 incorporating Span 80 and prepared at 30 °C, are denoted 
F1, F2 and F3,  respectively; F4 contain drug/polymer ratio 1:3, Span 80 and prepared at 10 °C; F5 and F6  contains 




The quantitative data were expressed as 
mean ± standard deviation (SD), and 
statistical analysist on the data were 
performed using one-way ANOVA (Graph 
Pad Prism 5). Differences between 
formulations were considered to be 




Characteristics of microspheres 
 
The microspheres were white, free-flowing 
and spherical. The yield varied from 72 - 85 
%. The quantitative characteristics of the 
microspheres are shown in Table 1. Carr’s 
index, which is a measure of flow property, 
was < 10 for all the formulations suggesting 
that they possessed excellent flow properties 
[10]. Higher polymer/drug ratio, processing 
temperature and surfactant HLB value of 
Span lead to increase in   the mean particle 
size of microspheres. The entrapment 
efficiency of the various microspheres was in 
the range 70.8 to 92.4 %. Formulation F3 had 
higher drug loading than F6 (p ≤0.05). Higher 
polymer/drug ratio, Span 80 and processing 
temperature of 10 and 30 °C favoured higher 
drug entrapment. 
 
Scanning electron microscopy (SEM) 
 
The SEMs of the microspheres are displayed 
in Fig 1 with Fig 1A (F4) showing the general 
appearance of the microspheres. F3 (Fig 1B) 
had a smooth surface without visible 
evidence of drug particles on its surface while 
F6 (Fig 1C) shows the presence of drug 
particles on the microsphere surface. Fig 1D 
(SEM of F5) indicate some holes and 




Fig 1: SEM photomicrographs of some microsphere 
formulations: (A) = F4(X 50); (B) = F3(X 200); (C) = F6(X 
50), and shows the presence of drug particles on 
microsphere surface; and (D) = F5(X 200), and shows 
holes and fractures on microsphere surface 
 
In vitro drug release 
 
Higher polymer/drug ratio, lower processing 
temperature and low HLB value of Span had 
an elevated effect on the sustained release 
characteristics of the microspheres.  
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Fig 2: Effect of drug/polymer ratio on drug release from 




Fig 3: Effect of processing temperature on drug release 





Fig 4: Effect of HLB value of Span on drug release from 






The increase in particle size of the 
microspheres with increase in polymer/drug 
ratio was due to the fact that the viscosity of 
the dispersed phase increased with increase 
in polymer/drug ratio, resulting in larger 
emulsion droplets which were difficult to 
break and, precipitated to become the 
microspheres [10]. Increase in temperature 
from 10 to 35 °C favoured formation of larger 
microspheres and this may be explained by 
the likelihood that at the lower temperature, 
when the polymeric phase was added to the 
oil phase and stirred, extensive emulsification 
of the polymeric phase occurred with the 
solvent in the polymeric phase diffusing into 
the outer oil phase, and evaporating from the 
system, and thus resulting in small-size 
microparticles, However, the higher 
temperature increased the rate of solvent 
evaporation with the emulsion droplets 
hardening faster and the stirrer shear force 
unable to break the droplets, thus leading to 
formation of larger particles [1,6].  
 
The surfactant type used also affected 
particle size as Span 80 (HLB value, 4.3) 
resulted in the formation of comparatively 
smaller particle than Span 20 (HLB value, 
8.6). This may be due to better stabilization of 
the emulsified droplets at the lower HLB 
value as Span 20 may have facilitated 





The increase in drug entrapment efficiency 
with increase in polymer/drug ratio may be 
attributed to increase in polymer viscosity 
with the result that the microsphere hinders 
escape of the entrapped drug. Formulations 
F3 and F4 showed > 90 % entrapment 
efficiency, suggesting that process 
temperatures ≤ 30 °C had no effect on drug 
entrapment. However, at 35 °C, increased 
solvent evaporation created holes and 
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fractures in the microsphere (F5, Fig 1D). 
These flaws constituted channels for the 
escape of the entrapped drug into the 
processing medium, leading to low drug 
entrapment.  
  
 Drug release 
  
 As polymer/drug ratio increased, drug release 
became more sustained because the 
polymeric phase became more viscous and 
this, in turn, strongly shielded the drug and 
hampered the diffusion of the dissolution 
medium into microsphere core to dissolve the 
drug as well as the diffusion of the dissolved 
drug out of the microsphere [11-13]. Lower 
processing temperature reduced the rate of 
drug release from the microspheres.  
 
 The photomicrographs indicate that while the 
microspheres formulated at 10 °C had no 
holes on their surfaces, those formulated at 
30 and 35 °C showed the presence of either 
holes or holes plus fractures on their 
surfaces. These flaws probably acted as 
channels for the dissolution medium to 
access the core of the microspheres as well 
as diffusion of the dissolved drug from the 
microspheres.  
 
 Formulation F6 released drug in a faster 
manner than F3 due probably to the higher 
HLB value of Span 80 which facilitated the 
formation of a more stable microsphere with 
a greater capacity to retard drug diffusion 
than the microspheres (F3) prepared with 
Span 20 as the emulsifying agent.  
  
 CONCLUSION  
  
 Formulation F4, which combined three 
optimized process factors, namely, Span 80 
(HLB value, 4.3), processing temperature of 
10 °C and drug/polymer ratio 1:3, yielded the 
satisfactory sustained theophylline release 
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